MAGIC MUSHROOM NEWS
January 26th 2023
"My sense of self has always felt like a robust, unshakeable part of my existence, so it came as something of a shock to have it temporarily obliterated.
The agent responsible for this unusual experience was psilocybin, a chemical found in magic mushrooms. I have often reported on research into the possible use of psilocybin and other psychoactive compounds to treat depression, so was curious to volunteer for a study assessing the safety of psilocybin in people with no known mental health conditions."
January 17th 2020
January 13th 2020
Psychedelic Magic Mushroom Therapy moves towards FDA approval
"Just a few years ago, if you wanted to hear about the benefits of psychedelic drugs, your best bet was to head over to the parking lot outside the local jam band concert and flag down the guy in the tie-dye selling “magic mushrooms.” Today there are better options. You could, for instance, fly down to the Waldorf Astoria’s gated beachside resort in Boca Raton, Fla., and—between spa appointments and rounds of golf—take in the keynote address at the CNS Summit, an annual Big Pharma conference." Read more here.
December 23rd 2019
"Magic mushrooms" may have moved one step closer to becoming a treatment for depression.
The active ingredient in psychedelic mushrooms is called psilocybin -- and a new British study suggests it could safely be used to treat depression when other drugs have failed, offering hope to millions of patients worldwide.
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
December 1st 2019
John Hopkins Medicine opens enrollment for volunteers on psilocybin research study.
"We are seeking volunteers with a diagnosis of cancer to participate in a scientific study of states of consciousness brought about by psilocybin, and their impact on psychological distress and spirituality.
The study is conducted in a comfortable and supportive setting, Volunteers enrolled in the study will receive careful preparation and two sessions in which they will receive psilocybin. Structured and professional guidance will be provided during the session and afterwards to facilitate integration of the experiences.
After each session, questionnaires and interviews will be used to assess the effects of the psilocybin on consciousness, mood, and behavior.
Nov 5th 2019
